Carl Urban

5.5k total citations
94 papers, 4.2k citations indexed

About

Carl Urban is a scholar working on Molecular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Carl Urban has authored 94 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Medicine, 39 papers in Epidemiology and 33 papers in Infectious Diseases. Recurrent topics in Carl Urban's work include Antibiotic Resistance in Bacteria (53 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). Carl Urban is often cited by papers focused on Antibiotic Resistance in Bacteria (53 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). Carl Urban collaborates with scholars based in United States, China and Australia. Carl Urban's co-authors include James J. Rahal, Noriel Mariano, Sorana Segal‐Maurer, N Mariano, Patricia A. Bradford, John Quale, David Landman, Karen Bush, Steven J. Projan and Christopher Cortes and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Carl Urban

91 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Urban United States 32 3.0k 1.4k 1.2k 1.1k 827 94 4.2k
D. M. Livermore United Kingdom 22 3.7k 1.2× 1.2k 0.8× 1.0k 0.8× 1.3k 1.2× 638 0.8× 25 4.8k
Simone Ambretti Italy 34 2.8k 0.9× 1.4k 1.0× 1.6k 1.3× 689 0.6× 586 0.7× 146 4.3k
Maria Souli Greece 32 2.5k 0.8× 1.2k 0.9× 919 0.7× 670 0.6× 516 0.6× 71 3.3k
Amy J. Mathers United States 34 4.0k 1.3× 1.4k 1.0× 1.1k 0.9× 1.7k 1.5× 788 1.0× 101 5.5k
Irene Galani Greece 32 2.6k 0.9× 1.2k 0.9× 838 0.7× 800 0.7× 421 0.5× 77 3.3k
Francesco Luzzaro Italy 34 3.5k 1.2× 826 0.6× 1.1k 0.9× 1.5k 1.3× 529 0.6× 112 4.3k
Alexandre Prehn Zavascki Brazil 35 3.5k 1.2× 2.4k 1.7× 1.5k 1.3× 629 0.6× 589 0.7× 116 4.9k
Jesús Oteo Spain 35 2.6k 0.9× 663 0.5× 1.3k 1.0× 1.2k 1.1× 586 0.7× 152 4.0k
Patricia J. Simner United States 38 3.3k 1.1× 1.2k 0.9× 1.4k 1.2× 1.2k 1.1× 880 1.1× 147 5.2k
Simona Bratu United States 24 2.8k 0.9× 1.1k 0.8× 609 0.5× 1.0k 0.9× 472 0.6× 31 3.2k

Countries citing papers authored by Carl Urban

Since Specialization
Citations

This map shows the geographic impact of Carl Urban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Urban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Urban more than expected).

Fields of papers citing papers by Carl Urban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Urban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Urban. The network helps show where Carl Urban may publish in the future.

Co-authorship network of co-authors of Carl Urban

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Urban. A scholar is included among the top collaborators of Carl Urban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Urban. Carl Urban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Dakai, Hangyu Zhou, Lulan Wang, et al.. (2023). Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA. Emerging infectious diseases. 29(2). 371–380. 4 indexed citations
2.
Mäurer, J., Glenn Turett, Carl Urban, et al.. (2023). A case of Lactobacillus jensenii associated native valve endocarditis. IDCases. 32. e01806–e01806. 5 indexed citations
3.
Wu, Yuexiu, Anna Kula, Nishant Prasad, et al.. (2022). Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at an NYC Hospital. International Journal of Infectious Diseases. 118. 214–219. 2 indexed citations
4.
Khan, Sikandar Z., et al.. (2021). Novel double beta-lactam therapy for Granulicatella adiacens infective endocarditis. IDCases. 24. e01082–e01082. 2 indexed citations
5.
6.
Gándara, María Pardos de la, Judith Berger, David Burstein, et al.. (2016). MRSA Causing Infections in Hospitals in Greater Metropolitan New York: Major Shift in the Dominant Clonal Type between 1996 and 2014. PLoS ONE. 11(6). e0156924–e0156924. 28 indexed citations
7.
Hagihara, Mao, Jared L. Crandon, Carl Urban, & David P. Nicolau. (2013). Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs. Journal of Antimicrobial Chemotherapy. 68(7). 1616–1618. 16 indexed citations
8.
Urban, Carl, Noriel Mariano, Patricia A. Bradford, et al.. (2010). Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagnostic Microbiology and Infectious Disease. 66(4). 402–406. 27 indexed citations
9.
Urban, Carl, et al.. (2009). Tricuspid valve endocarditis caused by Haemophilus parainfluenzae: a case report and review of the literature. Diagnostic Microbiology and Infectious Disease. 64(2). 216–219. 18 indexed citations
10.
Urban, Carl, Patricia A. Bradford, Margareta Tuckman, et al.. (2008). Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities. Clinical Infectious Diseases. 46(11). e127–e130. 72 indexed citations
11.
Segal‐Maurer, Sorana, Noriel Mariano, Carl Urban, et al.. (2005). Increased Mortality Associated With a Clonal Outbreak of Ceftazidime-ResistantKlebsiella pneumoniae: A Case–Control Study. Infection Control and Hospital Epidemiology. 26(1). 63–68. 16 indexed citations
12.
Segal‐Maurer, Sorana, et al.. (2001). Nosocomial Transmission of Imipenem-Resistant Pseudomonas Aeruginosa Following Bronchoscopy Associated With Improper Connection to the STERIS SYSTEM 1 Processor. Infection Control and Hospital Epidemiology. 22(7). 409–413. 70 indexed citations
13.
Urban, Carl, Xilin Zhao, Noriel Mariano, et al.. (2001). Fluoroquinolone‐ResistantStreptococcus pneumoniaeAssociated with Levofloxacin Therapy. The Journal of Infectious Diseases. 184(6). 794–798. 88 indexed citations
14.
Urban, Carl, et al.. (2001). Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI 21 and Cecropin P1 . Antimicrobial Agents and Chemotherapy. 45(3). 994–995. 40 indexed citations
15.
Kreiswirth, Barry N., et al.. (1998). Mycobacterium tuberculosis Specimen Contamination Revisited: The Role of Laboratory Environmental Control in a Pseudo-outbreak. Infection Control and Hospital Epidemiology. 19(2). 101–105. 20 indexed citations
16.
Urban, Carl & James J. Rahal. (1997). Klebsiella and extended spectrum β-lactamases. International Journal of Antimicrobial Agents. 8(1). 37–43. 10 indexed citations
17.
Urban, Carl, et al.. (1996). CURRENT PERSPECTIVES ON MULTIDRUG-RESISTANT BACTERIA. Infectious Disease Clinics of North America. 10(4). 939–957. 19 indexed citations
18.
19.
Bradford, Patricia A., Carl Urban, Anil K. Jaiswal, et al.. (1995). SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrobial Agents and Chemotherapy. 39(4). 899–905. 105 indexed citations
20.
Danna, Paolo, et al.. (1991). Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. The Lancet. 337(8740). 511–514. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. M. Livermore Breakdown of academic impact, for papers by Simone Ambretti Breakdown of academic impact, for papers by Maria Souli Breakdown of academic impact, for papers by Amy J. Mathers Breakdown of academic impact, for papers by Irene Galani Breakdown of academic impact, for papers by Francesco Luzzaro Breakdown of academic impact, for papers by Alexandre Prehn Zavascki Breakdown of academic impact, for papers by Jesús Oteo Breakdown of academic impact, for papers by Patricia J. Simner Breakdown of academic impact, for papers by Simona Bratu
Rankless by CCL
2026